BENNETT C FRANK — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

BENNETT C FRANK has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $19.80M.

Profile

BENNETT C FRANK

C. Frank Bennett is an executive at Ionis Pharmaceuticals, serving as the Executive Vice President and Chief Scientific Officer. He has been involved in the development of antisense technology and has contributed to the company's drug pipeline targeting various diseases.

RoleEVP, Chief Scientific Officer
Notability30/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-07-09IONSIONIS PHARMACEUTICALS INCS — Open-market sale15.0K$85.46$1.28M
2026-07-09IONSIONIS PHARMACEUTICALS INCJ — Other acquisition / disposition15.0K$0.00
2026-07-09IONSIONIS PHARMACEUTICALS INCS — Open-market sale5.5K$83.58$463K
2026-03-05IONSIONIS PHARMACEUTICALS INCS — Open-market sale [10b5-1]802$80.76$65K
2026-03-05IONSIONIS PHARMACEUTICALS INCS — Open-market sale [10b5-1]12.7K$79.88$1.01M
2026-03-05IONSIONIS PHARMACEUTICALS INCS — Open-market sale [10b5-1]71.6K$79.10$5.66M
2026-03-05IONSIONIS PHARMACEUTICALS INCM — Option exercise [10b5-1]48.6K$60.89$2.96M
2026-03-05IONSIONIS PHARMACEUTICALS INCM — Option exercise [10b5-1]16.5K$32.60$537K
2026-03-03IONSIONIS PHARMACEUTICALS INCJ — Other acquisition / disposition261$48.87$13K
2026-02-14IONSIONIS PHARMACEUTICALS INCJ — Other acquisition / disposition0$0.00
2026-02-04IONSIONIS PHARMACEUTICALS INCS — Open-market sale16.5K$83.03$1.37M
2026-02-04IONSIONIS PHARMACEUTICALS INCM — Option exercise16.5K$32.60$537K
2026-02-04IONSIONIS PHARMACEUTICALS INCS — Open-market sale48.6K$83.03$4.04M
2026-02-04IONSIONIS PHARMACEUTICALS INCM — Option exercise48.6K$60.89$2.96M
2026-02-04IONSIONIS PHARMACEUTICALS INCS — Open-market sale20.0K$82.60$1.65M
2026-02-03IONSIONIS PHARMACEUTICALS INCS — Open-market sale5.9K$82.95$488K
2026-02-03IONSIONIS PHARMACEUTICALS INCA — Grant or award11.4K$0.00
2026-01-21IONSIONIS PHARMACEUTICALS INCS — Open-market sale9.0K$75.15$675K
2026-01-21IONSIONIS PHARMACEUTICALS INCM — Option exercise21.1K$0.00
2025-09-05IONSIONIS PHARMACEUTICALS INCS — Open-market sale6.0K$59.60$358K

Companies — Last 90 Days

Frequently Asked Questions

Who is BENNETT C FRANK?

C. Frank Bennett is an executive at Ionis Pharmaceuticals, serving as the Executive Vice President and Chief Scientific Officer. He has been involved in the development of antisense technology and has contributed to the company's drug pipeline targeting various diseases.…

How many SEC Form 4 filings has BENNETT C FRANK submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has BENNETT C FRANK been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 14 open-market sales ($19.80M) across all tracked filings.

Where can I see all of BENNETT C FRANK's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live BENNETT C FRANK profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.